Description |
angiopoietin like 4 |
fibroblast growth factor receptor 4 |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Apolipoprotein A1 levels ( 32203549)
- Coronary artery disease ( 29212778)
- Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) ( 28714975)
- HDL cholesterol ( 24097068 28270201 24507774 19060906 30275531 25961943 20686565)
- HDL cholesterol levels ( 32203549 28334899 30698716)
- HDL cholesterol levels in current drinkers ( 30698716)
- HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- HDL cholesterol levels x long total sleep time interaction (2df test) ( 31719535)
- HDL cholesterol levels x short total sleep time interaction (2df test) ( 31719535)
- High density lipoprotein cholesterol levels ( 33339817)
- High light scatter reticulocyte count ( 32888494)
- High light scatter reticulocyte percentage of red cells ( 32888494)
- Mean spheric corpuscular volume ( 32888494)
- Metabolic syndrome ( 31589552)
- Metabolite levels (lipoprotein measures) ( 27005778)
- Myocardial infarction ( 33532862)
- Phospholipid levels in large HDL ( 29084231)
- Red cell distribution width ( 32888494)
- Reticulocyte count ( 32888494)
- Reticulocyte fraction of red cells ( 32888494)
- Total cholesterol levels in HDL ( 29084231)
- Total triglycerides levels ( 29084231)
- Triglyceride levels ( 32203549 32154731 33339817 30698716)
- Triglyceride levels in current drinkers ( 30698716)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Triglycerides ( 24507774 30275531 25961943 27036123)
- Waist-to-hip ratio adjusted for BMI (additive genetic model) ( 30778226)
|
- Activated partial thromboplastin time ( 22703881)
- Apolipoprotein A1 levels ( 32203549)
- Body fat distribution (arm fat ratio) ( 30664634)
- Body fat distribution (trunk fat ratio) ( 30664634)
- Body shape index ( 34021172)
- Circulating fibroblast growth factor 23 levels ( 30217807)
- Height ( 28552196 25282103 31562340)
- Hemoglobin levels ( 32327693)
- Hip circumference adjusted for BMI ( 34021172)
- Hip index ( 34021172)
- Hip shape (DXA scan) ( 30320955)
- Narrowest width of the femoral neck ( 30888730)
- Nonsyndromic cleft lip ( 31609978)
- Type 2 diabetes ( 32499647 30718926)
- Waist circumference adjusted for BMI (adjusted for smoking behaviour) ( 28443625)
- Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) ( 28448500)
- Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) ( 28443625)
- Waist circumference adjusted for BMI in active individuals ( 28448500)
- Waist circumference adjusted for BMI in non-smokers ( 28443625)
- Waist circumference adjusted for BMI in smokers ( 28443625)
- Waist circumference adjusted for body mass index ( 34021172 25673412 28448500)
- Waist-hip index ( 34021172)
- Waist-to-hip ratio adjusted for BMI ( 34021172 26426971)
- Waist-to-hip ratio adjusted for BMI (additive genetic model) ( 30778226)
- Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) ( 28443625)
- Waist-to-hip ratio adjusted for BMI (age <50) ( 26426971)
- Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction) ( 28443625)
- Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) ( 26426971)
- Waist-to-hip ratio adjusted for body mass index ( 26785701 25673412)
|
Interacting Genes |
9 interacting genes:
AURKA
BRMS1
CASP8
CDKN2A
CDKN2C
ESR1
FBXW7
FGFR4
TGFB1
|
85 interacting genes:
ABCB5
AKT1
ANGPTL4
ARAF
ARNT
BECN1
BLID
CASC3
CBLC
CCND2
CCNE1
CD44
CDH2
CDK4
CDK6
CDKN2A
CDKN2B
CDKN2C
DIRAS3
EPHA2
EPHA4
EPSTI1
ERBB2
ERRFI1
FGF1
FGF17
FGF18
FGF19
FGF2
FGF3
FGF4
FGF5
FGF6
FGF7
FGF8
FGF9
FZR1
GLCE
GLIS2
GRM1
HGF
HIF1A
IFT80
IGF1R
KDELR2
LATS2
LRATD2
MAP2K5
MAP2K6
MAP3K5
MAPK14
MDM4
MET
MSH2
MTA3
MYC
NF2
NSD3
OSGIN1
PDGFRA
PDLIM2
PLCG1
PPP3CA
PSMC3IP
PTPN11
PTPN12
PTPN6
PTPRR
RAF1
RASL10B
RASSF1
RNF20
ROS1
SCGB3A1
STAT1
STAT3
STC2
STK11
TEAD2
TERT
THRSP
TP53
TSC1
TTYH2
WIF1
|
Entrez ID |
51129 |
2264 |
HPRD ID |
16173 |
00625 |
Ensembl ID |
ENSG00000167772
|
ENSG00000160867
|
Uniprot IDs |
Q9BY76
|
B4DVP5
J3KPQ0
P22455
|
PDB IDs |
6EUB
6U0A
6U1U
6U73
|
1QCT
4QQ5
4QQC
4QQJ
4QQT
4QRC
4R6V
4TYE
4TYG
4TYI
4TYJ
4UXQ
4XCU
5JKG
5NUD
5NWZ
5XFF
5XFJ
6IUO
6IUP
6J6Y
6JPE
6JPJ
6NVG
6NVH
6NVI
6NVJ
6NVK
6V9C
6YI8
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|